FAS and pancreatic adenocarcinoma: In conclusion, concerted multiple changes rather than single or few perturbations of death receptor signalling are likely to be responsible for the resistance of pancreatic adenocarcinoma cells to CD95- and TRAIL-R-mediated apoptosis.